Neurogenic Vs Vascular Mechanisms of Sumatriptan and Ergot Alkaloids in Migraine

1 Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307–12.

2 Jansen I Edvinsson L Mortensen A Olesen J. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5HT₁-like receptor. Cephalalgia 1992;12:202–5.

3 Jansen I Olesen J Edvinsson L. 5-hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993;147:141–50.

4 Hamel E Bouchard D. Contractile 5HT receptors in human isolated pial arterioles: correlation with 5HT binding sites. Br J Pharmacol 1991;102:227–33.

5 Hamel E Fan E Linville D Ting V Villemure JG Chia LS Expression of mRNA for the serotonin 5-hydroxytryptamine_1Dβ receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993;44:242–6.

6 Rebeck GW Maynard KI Hyman BT Moskowitz MA . Selective 5HT_1Dα serotonin receptor gene expression in trigeminal ganglia: implication for antimigraine drug development. Proc Natl Acad Sci USA 1994;94:3666–9.

7 Bouchelet J Cohen Z Case B Sequael P Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 1996;50:219–23.